Japay, Brenda T.

HRN: 21-06-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2022
CEFUROXIME 1.5GM (VIAL)
04/10/2022
04/17/2022
IV
1.5gm, Then 750mg
Q8H
OR Prophylaxis
04/12/2022
CEFUROXIME 500MG (TAB)
04/12/2022
04/19/2022
PO
500
BID
S/P EL TAHBSO
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: